jueves, 14 de diciembre de 2023

FDA approves eflornithine for adult and pediatric patients with high-risk neuroblastoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-eflornithine-adult-and-pediatric-patients-high-risk-neuroblastoma?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario